应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02315 百奥赛图-B
休市中 01-30 16:08:02
43.880
-0.120
-0.27%
最高
63.000
最低
42.580
成交量
1,243万
今开
44.860
昨收
44.000
日振幅
46.41%
总市值
196.14亿
流通市值
48.71亿
总股本
4.47亿
成交额
6.10亿
换手率
11.20%
流通股本
1.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股百奥赛图盘中涨超24%!预计全年营收增长约40%,纯利增长约400%
老虎资讯综合 · 01-30 09:57
港股百奥赛图盘中涨超24%!预计全年营收增长约40%,纯利增长约400%
港股异动 | 百奥赛图-B(02315)盈喜后涨近13% 预计全年营收增长约40% 纯利增长约400%
智通财经 · 01-30 09:43
港股异动 | 百奥赛图-B(02315)盈喜后涨近13% 预计全年营收增长约40% 纯利增长约400%
港股公告掘金 | 牧原股份启动港股IPO 舜宇光学科技预期2025年归母净利增加70%至75%
智通财经 · 01-29 23:03
港股公告掘金 | 牧原股份启动港股IPO 舜宇光学科技预期2025年归母净利增加70%至75%
百奥赛图-B(02315)发布2025年度业绩预告,预期归母净利润1.62亿元至1.82亿元 同比增加384.26%到443.88%
智通财经 · 01-29
百奥赛图-B(02315)发布2025年度业绩预告,预期归母净利润1.62亿元至1.82亿元 同比增加384.26%到443.88%
百奥赛图-B盘中异动 股价大涨5.17%报45.200港元
市场透视 · 01-28
百奥赛图-B盘中异动 股价大涨5.17%报45.200港元
百奥赛图-B(02315)拟使用闲置自有资金进行现金管理
智通财经 · 01-28
百奥赛图-B(02315)拟使用闲置自有资金进行现金管理
百奥赛图-B(02315)建议委任刘弘康为非执行董事
智通财经 · 01-27
百奥赛图-B(02315)建议委任刘弘康为非执行董事
百奥赛图:调整募投项目拟投入募集资金金额
公司公告 · 01-27
百奥赛图:调整募投项目拟投入募集资金金额
百奥赛图:拟以债转股方式对全资子公司增资5.5亿元
格隆汇资讯 · 01-27
百奥赛图:拟以债转股方式对全资子公司增资5.5亿元
2025第十一届中国最具影响力医药企业百强榜发布
江南时报网 · 01-26
2025第十一届中国最具影响力医药企业百强榜发布
百奥赛图-B盘中异动 股价大跌5.59%报41.520港元
市场透视 · 01-26
百奥赛图-B盘中异动 股价大跌5.59%报41.520港元
国泰海通证券:首予百奥赛图-B(02315)“增持”评级 “抗体货架”重构新药研发生态
智通财经 · 01-26
国泰海通证券:首予百奥赛图-B(02315)“增持”评级 “抗体货架”重构新药研发生态
2025年业绩提前看 15家科创板公司归母净利润翻倍
大众证券报 · 01-23
2025年业绩提前看 15家科创板公司归母净利润翻倍
百奥赛图-B01月23日获主力加仓473.3万元
市场透视 · 01-23
百奥赛图-B01月23日获主力加仓473.3万元
港股异动 | 百奥赛图-B(02315)再涨近7% 公司已完成AI驱动抗体药物研发平台的本地化部署
智通财经 · 01-21
港股异动 | 百奥赛图-B(02315)再涨近7% 公司已完成AI驱动抗体药物研发平台的本地化部署
百奥赛图双平台协同发力:CRO业务稳健增长,全人源抗体授权放量打开长期成长空间
财评社 · 01-21
百奥赛图双平台协同发力:CRO业务稳健增长,全人源抗体授权放量打开长期成长空间
百奥赛图-B01月20日主力净流出246.6万元 散户资金买入
市场透视 · 01-20
百奥赛图-B01月20日主力净流出246.6万元 散户资金买入
百奥赛图-B盘中异动 急速下挫5.09%报37.700港元
市场透视 · 01-20
百奥赛图-B盘中异动 急速下挫5.09%报37.700港元
百奥赛图-B01月14日获主力加仓982.2万元
市场透视 · 01-14
百奥赛图-B01月14日获主力加仓982.2万元
百奥赛图-B盘中涨超12% 公司已完成AI驱动抗体药物研发平台的本地化部署
新浪港股 · 01-14
百奥赛图-B盘中涨超12% 公司已完成AI驱动抗体药物研发平台的本地化部署
加载更多
公司概况
公司名称:
百奥赛图-B
所属市场:
SEHK
上市日期:
--
主营业务:
百奥赛图(北京)医药科技股份有限公司是一家主要基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务的中国公司。该公司利用其自主开发的“RenMice”全人源抗体和T细胞受体(TCR)小鼠平台针对人体内潜在药物靶点进行规模化药物发现与开发。该公司主要业务包括创新模式动物销售、临床前药理药效评价服务及抗体开发。该公司还提供基因编辑服务。该公司在中国国内市场及海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":43.88,"timestamp":1769760482373,"preClose":44,"halted":0,"volume":12431912,"delay":0,"changeRate":-0.002727272727272669,"floatShares":111000000,"shares":447000000,"eps":0.084274,"marketStatus":"休市中","change":-0.12,"latestTime":"01-30 16:08:02","open":44.86,"high":63,"low":42.58,"amount":610475711,"amplitude":0.464091,"askPrice":44,"askSize":2500,"bidPrice":43.8,"bidSize":6500,"shortable":0,"etf":0,"ttmEps":0.324,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":7,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":44,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":6.713923692415809,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"百奥赛图","latestPrice":72.59,"timestamp":1769756400000,"preClose":66.58,"halted":0,"volume":5767500,"delay":0,"premium":"-46.16"}},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"1124857080","title":"港股百奥赛图盘中涨超24%!预计全年营收增长约40%,纯利增长约400%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124857080","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124857080?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:57","pubTimestamp":1769738220,"startTime":"0","endTime":"0","summary":"1月30日,$百奥赛图-B$盈喜后涨超24%,预计全年营收增长约40%,纯利增长约400%。消息面上,$百奥赛图$发布2025年度业绩预告,预计全年实现营收约13.69亿元-13.89亿元,较上年同期增加3.89亿元至4.08亿元,同比增幅为39.61%到41.65%;预计实现归母净利润约为1.62亿元-1.82亿元,较上年同期增加1.29亿元至1.49亿元,同比大幅增长384.26%至443.88%。","market":"hk","thumbnail":"https://static.tigerbbs.com/9bedac14febdf709f4cca99ceb4b91b1","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9bedac14febdf709f4cca99ceb4b91b1"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1a25853d795dfd507082cf4888ca5511","theme_name":"🔥热榜No.28 · 百奥赛图2025年度业绩预告显示营收增长约40%纯利增长约400%","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VT","BK0216","02315","BK4585","BK4588","688796"],"gpt_icon":0},{"id":"2607906696","title":"港股异动 | 百奥赛图-B(02315)盈喜后涨近13% 预计全年营收增长约40% 纯利增长约400%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607906696","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607906696?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:43","pubTimestamp":1769737415,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百奥赛图-B盈喜后涨近13%,截至发稿,涨8.82%,报47.88港元,成交额2771.5万港元。消息面上,百奥赛图发布2025年度业绩预告,预计全年实现营收约13.69亿元-13.89亿元,较上年同期增加3.89亿元至4.08亿元,同比增幅为39.61%到41.65%;预计实现归母净利润约为1.62亿元-1.82亿元,较上年同期增加1.29亿元至1.49亿元,同比大幅增长384.26%至443.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"1a25853d795dfd507082cf4888ca5511","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","VT","688796"],"gpt_icon":0},{"id":"2607367320","title":"港股公告掘金 | 牧原股份启动港股IPO 舜宇光学科技预期2025年归母净利增加70%至75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607367320","media":"智通财经","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607367320?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:03","pubTimestamp":1769698980,"startTime":"0","endTime":"0","summary":"【重大事项】卓正医疗(02677)1月29日至2月3日招股 预计2月6日上市牧原股份(02714)1月29日至2月3日招股 预计2月6日上市大族数控(03200)1月29日至2月3日招股 预计2月6日上市OSL集团(00863)拟折让约17.2%先旧后新配股 净筹约15.5亿港元中联重科(01157)拟发行60亿元于2031年到期的可换股债券中国通号(03969)2025年11月至12月共中标21","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1129","02315","BK0056","BK1521","LU1655091616.SGD","02517","02714","LU1211504680.USD","BK0196","VT","002714","BK1132","BK1504","BK4588","SG9999014674.SGD","02382","BK1170","BK0240","03939","BK1592","IE00B29SXG58.USD","BK0028","LU0326950275.SGD","BK0197","BK1161","BK0070","BK0187","LU1831875114.USD","09696","BK1608","BK1190","BK1589","BK4585","BK0195"],"gpt_icon":0},{"id":"2607704829","title":"百奥赛图-B(02315)发布2025年度业绩预告,预期归母净利润1.62亿元至1.82亿元 同比增加384.26%到443.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704829","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704829?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:34","pubTimestamp":1769675699,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥赛图-B 发布2025年度业绩预告,经公司财务部门初步测算,预计本集团2025年年度实现营业收入人民币13.69亿元至人民币13.89亿元,与上年同期相比,将增加人民币3.88亿元至人民币4.08亿元,同比增加39.61%至41.65%。预计本集团2025年年度实现归属于母公司所有者的净利润人民币1.62亿元至人民币1.82亿元,与上年同期相比,将增加人民币1.29亿元到人民币1.49亿元,同比增加384.26%到443.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399134.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","688796"],"gpt_icon":0},{"id":"2606713083","title":"百奥赛图-B盘中异动 股价大涨5.17%报45.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606713083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606713083?lang=zh_cn&edition=full","pubTime":"2026-01-28 14:07","pubTimestamp":1769580449,"startTime":"0","endTime":"0","summary":"2026年01月28日下午盘14时07分,百奥赛图-B股票出现波动,股价急速拉升5.17%。截至发稿,该股报45.200港元/股,成交量123.45万股,换手率1.11%,振幅6.79%。资金方面,该股资金流入2587.18万港元,流出1971.59万港元。百奥赛图-B股票所在的生物技术行业中,整体涨幅为0.95%。其相关个股中,迈博药业-B、方达控股、嘉和生物涨幅较大,振幅较大的相关个股有旺山旺水-B、迈博药业-B、嘉和生物,振幅分别为16.67%、14.00%、11.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128140729a45eff9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128140729a45eff9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2606519777","title":"百奥赛图-B(02315)拟使用闲置自有资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2606519777","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606519777?lang=zh_cn&edition=full","pubTime":"2026-01-28 08:07","pubTimestamp":1769558840,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥赛图-B(02315)发布公告,为提高公司自有资金使用效率,在确保不影响公司正常生产经营以及确保资金安全的前提下,公司拟合理利用部分闲置自有资金进行现金管理,可以提高自有资金使用效率,增加公司现金资产收益,为公司及股东获取更多投资回报。公司拟使用不超过人民币5亿元(含本数)的暂时闲置自有资金进行现金管理,在前述额度范围内,资金可以循环滚动使用。公司拟使用暂时闲置自有资金用于购买安全性高、流动性好、风险较低的银行及其他金融机构发行的理财产品进行委托理财。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","BK0216","688796","BK1161"],"gpt_icon":0},{"id":"2606887780","title":"百奥赛图-B(02315)建议委任刘弘康为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2606887780","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606887780?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:08","pubTimestamp":1769522909,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百奥赛图-B(02315)发布公告,经董事会提名委员会提名及董事会审议,董事会于2026年1月27日举行的董事会会议上建议委任刘弘康先生为非执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398230.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK1161","02315","688796"],"gpt_icon":0},{"id":"2606781179","title":"百奥赛图:调整募投项目拟投入募集资金金额","url":"https://stock-news.laohu8.com/highlight/detail?id=2606781179","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606781179?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:36","pubTimestamp":1769506562,"startTime":"0","endTime":"0","summary":"百奥赛图 公告,公司因实际募集资金净额低于原计划募投项目拟投入金额,结合实际情况调整募投项目拟投入金额。调整后拟使用募集资金总额为11.441亿元,不足部分由自有或自筹资金解决。本次调整不会改变募集资金用途,符合相关法律法规要求,并已履行董事会及审计委员会审议程序,保荐人出具无异议核查意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127180351a45b925e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127180351a45b925e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2606811077","title":"百奥赛图:拟以债转股方式对全资子公司增资5.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606811077","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606811077?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:30","pubTimestamp":1769506234,"startTime":"0","endTime":"0","summary":"格隆汇1月27日丨百奥赛图(688796.SH)公布,为缓解江苏百奥的资金压力,优化其内部资源配置及资产负债结构,百奥赛图拟以对江苏百奥55,000万元的债权以债转股的方式,转为对江苏百奥的增资款,其中16,500万元计入注册资本,38,500万元计入资本公积。相关债权不存在抵押、质押,亦不存在涉及有关债权的重大争议、诉讼或仲裁事项、查封或者冻结等司法措施。本次增资实施前,江苏百奥的注册资本为1,111.1111万元人民币,百奥赛图持有江苏百奥100%的股权;本次增资实施后,江苏百奥的注册资本将增加至17,611.1111万元,公司仍持有江苏百奥100%的股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127173521a45b797f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127173521a45b797f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2606758216","title":"2025第十一届中国最具影响力医药企业百强榜发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2606758216","media":"江南时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606758216?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:16","pubTimestamp":1769418960,"startTime":"0","endTime":"0","summary":"2026年1月26日,由董事会网、亚布力智库联合主办的“2025第十一届中国最具影响力医药企业百强榜”正式揭晓。在医药产业从“规模扩张”向“创新驱动”转型的关键期,本届百强榜的发布具有多重行业价值,成为解读中国医药产业格局的重要窗口。从本届榜单不难看出,中国医药产业正呈现“创新集聚、分化加剧、区域协同”的发展趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126172516a456f932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126172516a456f932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","06821","00874","BK1161","01530","09939","01477","02315","BK1574","01801","06160","BK1191","02196","BK1515","03692","01276","02607","02615"],"gpt_icon":0},{"id":"2606231372","title":"百奥赛图-B盘中异动 股价大跌5.59%报41.520港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606231372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606231372?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:43","pubTimestamp":1769391785,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘09时43分,百奥赛图-B股票出现异动,股价急速下挫5.59%。截至发稿,该股报41.520港元/股,成交量7.85万股,换手率0.07%,振幅7.87%。资金方面,该股资金流入82.627万港元,流出176.399万港元。最近的财报数据显示,该股实现营业收入6.81亿港元,净利润5,263.34万港元,每股收益0.13港元,毛利5.07亿港元,市盈率508.82倍。百奥赛图-B股票所在的生物技术行业中,整体跌幅为0.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126094306a6abf83b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126094306a6abf83b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2606262504","title":"国泰海通证券:首予百奥赛图-B(02315)“增持”评级 “抗体货架”重构新药研发生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2606262504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606262504?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:09","pubTimestamp":1769389785,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,国泰海通证券发布研报称,首次覆盖,给予百奥赛图-B“增持”评级。公司作为全球领先的创新药临床前CRO及生物技术公司,技术壁垒深厚,临床前产品与服务收入稳定增长,“千鼠万抗”计划进入兑现期。“千鼠万抗”计划进入兑现期,抗体开发与授权业务形成强力增长引擎百奥赛图以“抗体货架”为核心的创新模式,打破传统抗体开发的效率瓶颈,成为公司差异化竞争的核心引擎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","02315","688796","02611"],"gpt_icon":0},{"id":"2605407830","title":"2025年业绩提前看 15家科创板公司归母净利润翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2605407830","media":"大众证券报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605407830?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:10","pubTimestamp":1769177400,"startTime":"0","endTime":"0","summary":"根据Wind数据统计,截至2026年1月23日,科创板已有112家上市公司披露2025年年度业绩预告。例如,上海谊众预告2025年度实现归母净利润6000万元到7000万元,同比增长760.18%到903.54%。其中,2025年四季度预计实现营业收入34亿元至54亿元,同比增长105%至225%,环比增长29%至104%,实现归母净利润8.2亿元至9.7亿元,同比增长1225%至1450%,环比增长220%至278%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123221627a6a57c29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123221627a6a57c29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2605887407","title":"百奥赛图-B01月23日获主力加仓473.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605887407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605887407?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:16","pubTimestamp":1769156160,"startTime":"0","endTime":"0","summary":"01月23日, 百奥赛图-B股价涨9.57%,报收43.98元,成交金额1.4亿元,换手率2.79%,振幅18.09%,量比2.19。百奥赛图-B今日主力资金净流入473.3万元,连续3日净流入,上一交易日主力净流入207.0万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为66.67%,平均涨幅为8.47%。该股近5个交易日上涨1.62%,主力资金累计净流入849.4万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入3963.6万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162444a44d8e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162444a44d8e66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2605129183","title":"港股异动 | 百奥赛图-B(02315)再涨近7% 公司已完成AI驱动抗体药物研发平台的本地化部署","url":"https://stock-news.laohu8.com/highlight/detail?id=2605129183","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605129183?lang=zh_cn&edition=full","pubTime":"2026-01-21 10:27","pubTimestamp":1768962437,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百奥赛图-B(02315)再涨近7%,截至发稿,涨5.08%,报39.72港元,成交额2832.35万港元。消息面上,百奥赛图近日在互动平台表示,公司已完成AI驱动抗体药物研发平台的本地化部署,并实现其与公司核心业务千鼠万抗计划的全面协同。通过AI的本地化部署,公司正在建设抗体药物研发ai智能体。随着千鼠万抗计划与AI系统深度整合的持续推进,公司将为全球药企提供更加高效的研发工具和更为丰富的抗体分子库,帮助药企伙伴提高临床前PCC分子的研发效率,这也将推动抗体发现业务迈入全新发展阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK0216","02800","02315","BK1610","688796"],"gpt_icon":0},{"id":"2605125579","title":"百奥赛图双平台协同发力:CRO业务稳健增长,全人源抗体授权放量打开长期成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2605125579","media":"财评社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605125579?lang=zh_cn&edition=full","pubTime":"2026-01-21 06:17","pubTimestamp":1768947447,"startTime":"0","endTime":"0","summary":"BioMice平台是百奥赛图的基石业务,其核心优势在于拥有超过4,300种基因编辑动物及细胞模型,其中靶点人源化小鼠数量超过1,700种,位居行业前列。全球化是百奥赛图另一项突出的战略优势。在抗体药物开发领域,百奥赛图前瞻性地于2020年启动“千鼠万抗”计划,旨在系统性地针对人体内上千个潜在药物靶点,规模化进行全人源抗体发现。百奥赛图的营业收入从2020年的2.53亿元快速增长至2024年的9.80亿元,四年间年复合增长率高达40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121064037a4427dfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121064037a4427dfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2605512563","title":"百奥赛图-B01月20日主力净流出246.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2605512563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605512563?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:15","pubTimestamp":1768896930,"startTime":"0","endTime":"0","summary":"01月20日, 百奥赛图-B股价跌4.83%,报收37.80元,成交金额5350.8万元,换手率1.26%,振幅9.01%,量比0.63。百奥赛图-B今日主力资金净流出246.6万元,上一交易日主力净流入222.1万元。该股近5个交易日下跌13.47%,主力资金累计净流入1758.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入3411.7万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120162350a4402d7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120162350a4402d7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2605612552","title":"百奥赛图-B盘中异动 急速下挫5.09%报37.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605612552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605612552?lang=zh_cn&edition=full","pubTime":"2026-01-20 13:00","pubTimestamp":1768885237,"startTime":"0","endTime":"0","summary":"2026年01月20日下午盘13时00分,百奥赛图-B股票出现异动,股价大幅跳水5.09%。截至发稿,该股报37.700港元/股,成交量55.05万股,换手率0.50%,振幅8.31%。资金方面,该股资金流入654.746万港元,流出1208.18万港元。最近的财报数据显示,该股实现营业收入6.81亿港元,净利润5,263.34万港元,每股收益0.13港元,毛利5.07亿港元,市盈率465.15倍。百奥赛图-B股票所在的生物技术行业中,整体跌幅为2.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120130037953d7938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120130037953d7938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2603623226","title":"百奥赛图-B01月14日获主力加仓982.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603623226","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603623226?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:15","pubTimestamp":1768378559,"startTime":"0","endTime":"0","summary":"01月14日, 百奥赛图-B股价涨4.63%,报收44.74元,成交金额1.5亿元,换手率3.01%,振幅12.86%,量比1.13。百奥赛图-B今日主力资金净流入982.2万元,上一交易日主力净流入862.5万元。该股近5个交易日上涨25.91%,主力资金累计净流入2022.7万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2265.0万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162326a7195219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162326a7195219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2603665720","title":"百奥赛图-B盘中涨超12% 公司已完成AI驱动抗体药物研发平台的本地化部署","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665720","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603665720?lang=zh_cn&edition=full","pubTime":"2026-01-14 10:08","pubTimestamp":1768356480,"startTime":"0","endTime":"0","summary":" 百奥赛图-B盘中涨超12%,近三日累涨约30%。截至发稿,股价上涨7.58%,报46港元,成交额5387.96万港元。 1月13日,百奥赛图在互动平台表示,公司已完成AI驱动抗体药物研发平台的本地化部署,并实现其与公司核心业务千鼠万抗计划的全面协同。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-01-14/doc-inhhfrsv5260509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688796","BK0216","BK1161","02315"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.0023},{"period":"1month","weight":0.2431},{"period":"3month","weight":0.5671},{"period":"6month","weight":0.7242},{"period":"1year","weight":4.5756},{"period":"ytd","weight":0.2431}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图(北京)医药科技股份有限公司是一家主要基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务的中国公司。该公司利用其自主开发的“RenMice”全人源抗体和T细胞受体(TCR)小鼠平台针对人体内潜在药物靶点进行规模化药物发现与开发。该公司主要业务包括创新模式动物销售、临床前药理药效评价服务及抗体开发。该公司还提供基因编辑服务。该公司在中国国内市场及海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.018702},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052338},{"month":3,"riseRate":0.333333,"avgChangeRate":0.185414},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.066586},{"month":5,"riseRate":0.666667,"avgChangeRate":0.14952},{"month":6,"riseRate":0.333333,"avgChangeRate":0.011218},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.033427},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.055975},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}